Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Blood Cancers

Photomicrograph of Acute Myeloblastic Leukemia (AML), a cancer of white blood cell
December 28, 2021/Cancer/Blood Cancers

Uproleselan May Improve Remission, Reduce Side Effects in Patients with Acute Myeloid Leukemia

Study finds drug safe and effective when combined with chemotherapy

Mukherjee CQD 654×450
December 23, 2021/Cancer/Blood Cancers

Novel Program Optimizes Diagnostic and Treatment Strategies for Rare Diseases

Multidisciplinary team tackles the management of 84 uncommon cancers and blood disorders

Chimeric antigen receptor (CAR) therapy,
December 14, 2021/Cancer/Blood Cancers

Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma

Treatment may be a lifesaving option for patients with relapsed or refractory disease

nci-vol-2336_650x450
October 7, 2021/Cancer/Blood Cancers

Less-Intensive Therapies for Acute Myeloid Leukemia Tied to Higher Mortality Risks

Study reports on 11-year experience in AML

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

multiple myeloma
April 1, 2021/Cancer/Blood Cancers

CAR T-Cell Therapy Shows Promise in Treating Relapsed/Refractory Multiple Myeloma

Preliminary trial reports positive patient response

hematopoetic-cells_650x450

Molecular and Genetic Mechanisms in Bone Marrow Failure Syndromes and Myeloid Neoplasia

Results of two studies presented at the 2020 ASH Annual Meeting

nci multiple myeloma
February 24, 2021/Cancer/Blood Cancers

Azacitidine Shows Potential as a Treatment for Multiple Myeloma

Trial results point the way to further investigation

leukemia_650x450

Selective Targeting May Have Therapeutic Potential in TET2-Mutant Neoplasia

TETi76 eliminates TET2-mutant and TET-deficient cancer cells

platelets_650x450
January 7, 2021/Cancer/Blood Cancers

Pacritinib Moves Closer to FDA Approval for Myelofibrosis

Dose-finding trial adds to evidence of efficacy

nci-vol-2336_650x450

Machine Learning Improves the Subclassification and Prognostication of Acute Myeloid Leukemia

Four genomic clusters identified

BackPage 3 of 8Next

Advertisement

Ad